Using bacteria to deliver drugs

Tumours can be dense pockets of tissue that at their core contain very little oxygen. The dense nature of tumours makes it difficult for drugs to be effectively delivered to the central cells. The head of the Experiment Therapeutics axis, Dr. G. Batist, collaborated […]

Open access results lead to advances in acute lymphoblastic leukemia

The BCLQ collects samples coming from many types of cancers, including acute lymphoblastic leukemia (ALL). Select ALL samples were analyzed via RNA sequencing by the Leucegene group who went on to published their findings and ensured that their data […]

Bridging fundamental and clinical science using biobanked samples

Translational science refers to research performed in a lab, or fundamental research, which is then applied to patients in a clinical setting. It is unquestionably important to moving forward in the fight against cancer. This type of research requires collaborations between researchers […]

Testing the effectiveness of panobinostat in diffuse large B-cell lymphoma

In cells, DNA is wrapped around organizing proteins called histones. Different enzymes interact with the histones to make DNA more or less available to the cell. The histone modifying enzymes are known to be mutated in many diffuse […]

2018 RRCancer-TFRI Conference

It is with pleasure that we invite all members of RRCancer to our biennial conference to be held on Thursday, October 11, 2018. This joint RRCancer-TFRI meeting will take place at the Château Bromont Hotel immediately before the 60th annual meeting of the Club de Recherches Cliniques […]


Keep abreast of new technologies and advances in cancer diagnosis and treatment.

click here for the latest publications.